SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
26 hedge funds and large institutions have $420M invested in Sinovac Biotech, Ltd in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.38%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Morgan Stanley
New York
|
$50.6K |
Top Sellers
1 |
1
State Street
Boston,
Massachusetts
|
$0 |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$0 |
3 |
3
UBS Group
Zurich,
Switzerland
|
$10.1K |
4 |
4
Wells Fargo
San Francisco,
California
|
$80.6K |